← Leaderboards
Alan J Russell
Mellon Pitts Corporation (Mpc Corp)
$1,965,429
Attributed
$1,965,429
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $559.9K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$1,965,429 · 3
By mechanism
T32$1,570,445 · 1
R21$394,984 · 1
P41$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Mellon Pitts Corporation (Mpc Corp)
Same institution · by research overlap
- Hugh B Nicholas$937,939
- David W Deerfield$178,000
- Robert Charles Speth$1,075,660
- Lixing W Reneker$5,093,980
- Edward G Cape$0
Others in their field
Top investigators on “Biomedical Resource”
- Eric S Lander · Whitehead Institute For Biomedical Res$327,348,429
- Richard A Gibbs · Baylor College Of Medicine$197,881,494
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$159,861,320
- Ronald J Sokol · University Of Colorado Denver$154,805,139
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$154,215,387
- Joseph E Robertson · Oregon Health & Science University$128,745,682
Research focus
Biomedical ResourceEnzymesGallbladderStatistics /BiometryTechnology /TechniqueBioengineering /Biomedical Engineering
Grant awards (10)
Cellular Approaches to Tissue Engineering/Regeneration$346,909
T32 · FY2007 · EB · contact PI
Cellular Approaches to Tissue Engineering/Regeneration$350,574
T32 · FY2006 · EB · contact PI
Bioreactor Actuated Ovarian Development$209,307
R21 · FY2006 · EB · contact PI
Cellular Approaches to Tissue Engineering/Regeneration$350,574
T32 · FY2005 · EB
Bioreactor Actuated Ovarian Development$185,677
R21 · FY2005 · EB
Cellular Approaches to Tissue Engineering/Regeneration$350,574
T32 · FY2004 · EB
Cellular Approaches to Tissue Engineering/Regeneration$171,814
T32 · FY2003 · EB
RACEMIC IBUPROFEN RESOLUTION IN SUPER CRITICAL CO2 USING CHIRAL RESOLVING AGENT$0
P41 · FY2002 · RR
RACEMIC IBUPROFEN RESOLUTION IN SUPER CRITICAL CO2 USING CHIRAL RESOLVING AGENT$0
P41 · FY2002 · RR
RACEMIC IBUPROFEN RESOLUTION IN SUPER CRITICAL CO2 USING CHIRAL RESOLVING AGENT$0
P41 · FY2001 · RR